Skip to content
Screener

iRhythm Holdings, Inc. IRTC Total Liabilities & Equity

Total Liabilities & Equity at other companies

Baxter International logo
Baxter InternationalBAX
$19.85B-6.8%
Boston Scientific logo
Boston ScientificBSX
$44.35B+10.5%
Kestra Medical Technologies logo
Kestra Medical TechnologiesKMTS
$358.47M+21.2%
Owlet logo
OwletOWLT
$86.76M+68.8%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$166.35M-19.9%
Medtronic logo
MedtronicMDT
$93.03B+1.5%

Other financials

Income statement

See full
Revenue$224.2M+20.1%
Gross profit$163.2M+22.8%
Operating income-$2.5M+86.4%
Net income-$381.0K+97.3%
EPS (diluted)-$0.01+97.7%

Balance sheet

See full
Cash & equivalents$255.0M-19.7%
Total debt$76.3M-12.1%
Total equity$186.0M+79.4%
Total assets$1.1B+13.4%

Cash flow

See full
Operating cash flow$51.1M+84.7%
CapEx$13.6M+30.8%
Free cash flow$37.5M+117%

Valuation

See full
Market cap$4.2B-18.6%
Enterprise value$4.02B-18.4%
P/S5.1×-2.8×

Profitability

See full
Gross margin71.5%+1.7pp
Operating margin-3.3%-1.5pp
Net margin-7.3%-3.1pp
FCF margin4.7%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.4×-0.4×
Current ratio3.9×-1.2×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: iRhythm Holdings, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001388658-26-000072
Line itemJune 30, 2026December 31, 2025
Preferred stock, $0.001 par value – 5,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.001 par value – 100,000 shares authorized; 33,173 shares issued and 32,944 shares outstanding at June 30, 2026, and 32,526 shares issued and 32,297 shares outstanding at December 31, 20253332
Additional paid-in capital1,028,898980,757
Accumulated other comprehensive (loss) income(188)403
Accumulated deficit(817,760)(803,446)
Treasury stock, at cost; 229 shares at June 30, 2026 and December 31, 2025(25,000)(25,000)
Total stockholders’ equity185,983152,746
Total liabilities and stockholders’ equity$1,093,426$1,020,042

Item 1. Financial Statements (Unaudited):

FAQ

What is iRhythm Holdings, Inc.'s total liabilities & equity?
iRhythm Holdings, Inc. (IRTC) reported total liabilities & equity of $1.09B in Q2 2026.
How has iRhythm Holdings, Inc.'s total liabilities & equity changed year-over-year?
iRhythm Holdings, Inc.'s total liabilities & equity increased by 13.4% year-over-year, from $964.03M to $1.09B.
What is the long-term trend for iRhythm Holdings, Inc.'s total liabilities & equity?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc.'s total liabilities & equity has grown at a 14.8% compound annual growth rate (CAGR), from $511.74M to $1.02B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about iRhythm Holdings, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude